<code id='5FA5C5C66A'></code><style id='5FA5C5C66A'></style>
    • <acronym id='5FA5C5C66A'></acronym>
      <center id='5FA5C5C66A'><center id='5FA5C5C66A'><tfoot id='5FA5C5C66A'></tfoot></center><abbr id='5FA5C5C66A'><dir id='5FA5C5C66A'><tfoot id='5FA5C5C66A'></tfoot><noframes id='5FA5C5C66A'>

    • <optgroup id='5FA5C5C66A'><strike id='5FA5C5C66A'><sup id='5FA5C5C66A'></sup></strike><code id='5FA5C5C66A'></code></optgroup>
        1. <b id='5FA5C5C66A'><label id='5FA5C5C66A'><select id='5FA5C5C66A'><dt id='5FA5C5C66A'><span id='5FA5C5C66A'></span></dt></select></label></b><u id='5FA5C5C66A'></u>
          <i id='5FA5C5C66A'><strike id='5FA5C5C66A'><tt id='5FA5C5C66A'><pre id='5FA5C5C66A'></pre></tt></strike></i>

          leisure time

          leisure time

          author:comprehensive    Page View:97
          STR/AFP via Getty Images

          A traditional Chinese medicine compound used for cardiac benefits might help reduce the incidence of major adverse cardiac and cerebrovascular events and even cardiac death rates, according to a new study published Tuesday in the Journal of the American Medical Association.

          However, some outside experts expressed skepticism about the result.

          advertisement

          Tongxinluo — which means “to open (tong) the network (luo) of the heart (xin)” in Mandarin —  is a traditional Chinese medicine compound made out of a mixture of powders and extracts from plants, centipedes, cicadas, and other sources.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          UnitedHealth starts bidding war with $3.3 billion offer for Amedisys
          UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

          UnitedHealthGroupisattemptingtobuyAmedisysfor$3.3billion.CourtesyUnitedHealthGroupThere’snowatwo-par

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Getting Alzheimer's drug Leqembi to patients can be a challenge

          BenMargot/APAhostofhurdlesareslowingtheadoptionofthenewAlzheimer’sdrugLeqembi,expertsinvolvedinthetr